Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Tax Rate (2019 - 2026)

Catalyst Pharmaceuticals filings provide 8 years of Tax Rate readings, the most recent being 24.33% for Q1 2026.

  • On a quarterly basis, Tax Rate rose 392.0% to 24.33% in Q1 2026 year-over-year; TTM through Mar 2026 was 27.63%, a 33.0% increase, with the full-year FY2025 number at 26.79%, down 180.0% from a year prior.
  • Tax Rate hit 24.33% in Q1 2026 for Catalyst Pharmaceuticals, down from 36.12% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 63.52% in Q4 2023 to a low of 3.77% in Q4 2022.
  • Median Tax Rate over the past 5 years was 23.46% (2022), compared with a mean of 24.75%.
  • Biggest five-year swings in Tax Rate: crashed -3112bps in 2022 and later surged 6729bps in 2023.
  • Catalyst Pharmaceuticals' Tax Rate stood at 3.77% in 2022, then soared by 1784bps to 63.52% in 2023, then plummeted by -41bps to 37.34% in 2024, then dropped by -3bps to 36.12% in 2025, then tumbled by -33bps to 24.33% in 2026.
  • The last three reported values for Tax Rate were 24.33% (Q1 2026), 36.12% (Q4 2025), and 25.69% (Q3 2025) per Business Quant data.